Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 827 for “"BCR"”.
-
TARGETED COVALENT REVERSIBLE BCR-ABL INHIBITORS
… catalytic lysine-targeting reversible covalent BCR-ABL inhibitors with single-digit nanomolar potency against both wild type, and mutant ABL proteins using the carbonyl boronic acid warhead is reported. It is shown that the evolutionarily conserved lysine can be targeted selectively using mass …
-
Optimizing immunity against BCR-ABL positive leukemia
… by proliferation of cells expressing BCR-ABL fusion proteins. The BCR-ABL fusion proteins are tumor-specific antigens and represent reasonable targets for immunologic approaches against CML. We have utilized a free-solution-isoelectric focusing technique (FS-IEF) to obtain chaperone …
-
The analysis of B cell antigen receptor (BCR) mutants deficient in antigen-independent signaling reveals novel BCR-associated proteins
The B cell antigen receptor (BCR) is composed of the membrane-bound immunoglobulin (mIg) <br>and the Ig-alpha/Ig-beta heterodimer and plays a central role in development, survival, and activation <br>of B lymphocytes. During B cell development, the BCR seems to be able to generate signals in <br>an …
-
In vivo detection of the BCR/ABL1 protein
The BCR/ABL1 fusion protein is found in virtually all cases chronic myeloid leukemia (CML) and a large proportion of acute lymphoblastic leukemia (ALL). The fact that the BCR/ABL1 fusion protein is crucial for the development of leukemia makes this fusion protein an attractive target for therapy …
-
Src-Kinasen als Mediatoren Bcr-Abl-induzierter Leukämien
Bcr-Abl, eine onkogene Tyrosinkinase, ist maßgeblich an der Entstehung der chronischen myeloischen Leukämie (CML) sowie einem Teil der Fälle von akuter B-lymphoblastischer Leukämie (B-ALL) beteiligt. Die essentielle Rolle der Kinase-Aktivität von Bcr-Abl für dessen leukämogenes Potential konnte in …
-
Antisense BCR-ABL oligonucleotides in chronic myeloid leukemia
Dept. of Hematology University Hospital Nijmegen, 09 oktober 1997
-
Origin of Disease Heterogeneity in BCR-ABL1 Lymphoblastic Leukemia
BCR-ABL1 positive acute lymphoblastic leukemia (ALL) is an aggressive subtype of ALL that commonly appears in adults. Introduction of tyrosine kinase inhibitors into frontline treatments has significantly improved outcomes; however, the disease still frequently relapses and becomes refractory to …
-
EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA
… that we investigated the function of Egr-1 in BCR-ABL driven leukemia using a mouse m bone marrow transplantation (BMT) model. We observe that loss of Egr-1 accelerates the onset of BCR-ABL driven CML. Furthermore, through Facs analysis we showed that most animals developed myeloid leukemia, …
-
Reprogramming of myeloid progenitors by the BCR-ABL oncogene
The constitutive tyrosine kinase activity of the BCR-ABL oncogene is central for the pathogenesis of chronic myeloid leukaemia (CML). Clinical treatment of CML with the kinase inhibitor Imatinib Mesylate (IM) is a fundamental success demonstrating disease addiction upon BCR-ABL activity. However, …
-
Μελέτη του αντιγονικού υποδοχέα BCR στη χρόνια λεμφοκυτταρική λευχαιμία
… lymphocytes. The study of the B cell receptors (BCRs) in CLL has offered valuable biological insight; however, several issues remain unresolved. In the present study, we sought answers to these issues through the immunogenetic analysis of CLL and related entities. In particular, the study can be …
-
The role of BLNK, DOK-3 & DIP in BCR signaling
Engagement of the BCR leads to various cellular responses in B cells. Adaptor proteins were found to be responsible for co-ordinating activated upstream PTKs with downstream signaling events. In this study, we demonstrate the role of both a positive adaptor protein, BLNK and also that of a negative …
-
Actin assembly and disassembly factors regulate BCR organization and signaling
… cell (APC). The binding of the B cell receptor (BCR) to these Ags triggers dynamic, multi-scale reorganization of the BCR and associated signal transduction machinery. Initially, BCRs are gathered into microclusters that are dispersed throughout the B cell-APC contact site. Microclusters are then …
-
Regulation of BCR-ABL expression via its 3’untranslated region.
… between chromosomes 9 and 22 fuses the BCR gene with the ABL1 gene, and gives rise to the BCR-ABL gene. Expression of the BCR-ABL protein initiates and drives CML. The level of BCR-ABL expression is associated with disease progression and response to therapy, yet control of BCR-ABL …
-
The GAB2/SHP2 Pathway in BCR-ABL1-Induced Hematopoietic Neoplasia
BCR-ABL1 is a gene product of the t(9, 22) chromosomal translocation. It encodes a fusion protein with constitutively activated tyrosine kinase activity and is the direct cause of chronic myeloid leukemia (CML) and a subset of B-lymphoid acute lymphoblastic leukemia (B-ALL). ABL1-targeting tyrosine …
-
Role Of Gadd45a In BCR-ABL and NRASD12 Driven Leukemia
BCR-ABL is known as the most common translocation in the myeloproliferative (MPD) disorder chronic myelogenous leukemia (CML); it is the first leukemia to be described and associated with a consistent cytogenetic abnormality, termed the Philadelphia chromosome (Ph1). Ph1 is a shortened chromosome …
-
Leveraging BCR data to improve computational design of therapeutic antibodies
… quantities of high quality B cell receptor (BCR) data become available, the challenge of how to best utilise the data to improve the antibody development process remains. In the results chapters of this thesis, we begin by describing our novel approach to numbering antibody sequences, …
-
Molecular and functional studies of the BCR/ABL1 fusion gene
The BCR/ABL1 fusion gene is associated with chronic myeloid leukemia and a subgroup of acute lymphoblastic leukemia. The general aim of this thesis was to increase the understanding of BCR/ABL1-induced leukemogenesis by molecular and functional studies of this fusion gene. In Article I, an …
-
ΜΕΛΕΤΗ ΤΟΥ ΧΙΜΑΙΡΙΚΟΥ ΓΟΝΟΥ BCR/ABL ΣΤΗ ΧΡΟΝΙΑ ΜΥΕΛΟΓΕΝΗ ΛΕΥΧΑΙΜΙΑ
… DOUBLE: FIRST, THE (PCR) MOLECULAR DETECTION OF BCR/ABL REARRANGEMENT (FUSION), BY USING BIOTINYLATED OLIGONUCLEOTIDES, INSTEAD OF P LABELED OLIGOS, IN THE HYBRIDIZATION OF PCR PRODUCTS. SECOND, THE CORRELATION BETWEEN CLINICAL FEATURES AND MOLECULAR TYPE OF BCR/ABL REARRANGEMENT (FUSION). 15 CML …
Page 1 of 42